View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Baxter BioPharma Solutions

Seasonal Vaccine Manufacturing

Free White Paper

Seasonal Vaccine Manufacturing

By Baxter BioPharma Solutions

Seasonal Vaccine Manufacturing

By Baxter BioPharma Solutions
Enter your details to receive the free paper:

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting from annual strain selection.

The timeline for development of a seasonal influenza vaccine starts with a meeting by an FDA advisory committee in March to decide which strains to include in the next season’s vaccine which in turn must be produced, released, and distributed to pharmacies, clinics, and physician offices in as little as 6 months.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology